Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 June 2025 | Story Martinette Brits | Photo Supplied
South Campus
The University of the Free State’s South Campus is set to become the hub of a pioneering veterinary science programme — only the second of its kind in South Africa.

The University of the Free State (UFS) is advancing plans to establish a new veterinary science programme – set to become only the second of its kind in South Africa. This initiative includes the development of a professionally accredited Bachelor of Veterinary Science (BVSc) degree and a state-of-the-art veterinary teaching hospital on the South Campus in Bloemfontein. It will also leverage the university’s Paradys Experimental Farm, home to advanced agricultural infrastructure and established production animal herds.

“The UFS is planning a new veterinary programme, strategically supported by the unique infrastructure and resources of its South Campus,” says Prof Johan van Niekerk, Vice-Dean of Agriculture in the Faculty of Natural and Agricultural Sciences. “Located in close proximity to the Paradys Experimental Farm, the campus provides an ideal environment for practical veterinary training. The farm’s real-world livestock systems will offer students invaluable experiential learning opportunities in animal care, disease management, and sustainable agriculture.”

In her installation address delivered on Monday 9 June 2025, Prof Hester C. Klopper, Vice-Chancellor and Principal of the UFS, highlighted the importance of this development, noting that it will position the university as a key contributor to veterinary science education in South Africa. "The establishment of a veterinary science programme at the UFS reflects our commitment to transdisciplinary research and addressing national priorities through innovation in higher education. This initiative not only strengthens our role in advancing food security, animal health, and sustainable agriculture, but also positions the UFS as a pivotal contributor to the continent’s development goals in these critical sectors."

This move comes in direct response to the country’s pressing need for more veterinary professionals, a shortage that poses risks to food security, animal welfare, public health, and agricultural productivity.

According to a report by the Western Cape Government (South Africa is Bleeding Veterinarians, February 2023), South Africa has only 60 to 70 veterinarians per million people – far below the international norm of 200 to 400 per million. This critical gap underscores the urgency of expanding veterinary education and training opportunities.

“This initiative directly addresses a national priority while aligning with continental and global aspirations towards sustainable development – especially in the areas of modern agriculture, food security, and environmental sustainability,” says Dr Nalize Scheepers from the Department of Sustainable Food Systems and Development.

 

Building a foundation for veterinary excellence

Although still in the early stages, the project has received in-principle approval from the Minister of Higher Education and Training, the Department of Agriculture (DoA), the Department of Higher Education and Training (DHET), and the South African Veterinary Council (SAVC).

The university has been exploring the feasibility of this programme for the past five years, involving consultations with various stakeholders in the higher education and veterinary sectors. "As a public higher education institution, we are subject to national regulation and will confirm commencement dates once final approval and accreditation of the qualification are secured," says Dr Scheepers.

As part of this initiative, a veterinary academic hospital is planned on the South Campus. “The facility will feature clinical training facilities – providing students with supervised, hands-on experience in animal diagnosis, surgery, and treatment; public veterinary services – offering essential care to local farmers, livestock owners, and pet owners in the surrounding communities; and research support – enabling applied research in critical areas such as animal health, epidemiology, and public health,” says Prof van Niekerk.

Beyond supporting academic excellence, the planned hospital will play a vital role in serving the wider agricultural community. “The hospital will address the urgent shortage of veterinary services in the region and contribute to the province’s animal health and food security goals,” he adds.

Initially, the BVSc degree will be offered within the Faculty of Natural and Agricultural Sciences, with plans to establish a dedicated School of Veterinary Science as the programme develops. The initiative also supports the UFS One Health Initiative, creating broad opportunities for research and development.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept